| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 06/09/2005 | WO2005051911A1 4-phenylpiperidine derivatives as renin inhibitors |
| 06/09/2005 | WO2005051908A1 Indole derivatives for use as chemical uncoupler |
| 06/09/2005 | WO2005051387A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
| 06/09/2005 | WO2005051381A1 Substituted urea-octatydroindols as antagonists of melanin concentrating hormone receptor 1 (MCH1R) |
| 06/09/2005 | WO2005051380A1 Substituted urea-octahydroindols as antagonists of melanin concentrating hormone receptor 1 (mch1r) |
| 06/09/2005 | WO2005035508A3 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
| 06/09/2005 | US20050124677 Peptide deformylase inhibitors |
| 06/09/2005 | US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 06/09/2005 | US20050124656 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | US20050124640 Pyrimidine derivatives useful as inhibitors of PKC-theta |
| 06/09/2005 | US20050124634 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 06/09/2005 | US20050124633 For the treatment of myosin heavy chain-mediated diseases, and in particular, heart failure |
| 06/09/2005 | US20050124625 For example, ((2R,5S)-4-(8-cyano-quinolin-5-yl)-2,5-dimethyl-piperazine-1-carboxylic acid(4-trifluoromethyl-pyridin-3-yl)-amide); use in treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders |
| 06/09/2005 | US20050124619 Medical devices employing triazine compounds and compositions thereof |
| 06/09/2005 | US20050124614 E. g., 3,5-bis-trifluoromethylphenyl)-4-[(furan-2-ylmethyl)-aminocarbonyl]-2-methyl-1-oxo-1,2,3,4-tetrahydroisoquinoline;anticarcinogenic agents; antitumor agents; antiproliferative agents; activators of the caspase cascades; enzyme inhibitors used in combination with radiation or chemotherapy |
| 06/09/2005 | US20050124610 cyclin dependent kinase (CDK) inhibitors useful in treating or ameliorating a CDK mediated disorder consisting of cervical adenocarcinoma, colon carcinoma and malignant melanoma |
| 06/09/2005 | US20050124603 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 06/09/2005 | US20050124602 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; treating a thromboembolic disorder such as deep vein thrombosis or pulmonary embolism |
| 06/09/2005 | US20050124577 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 06/09/2005 | US20050124496 Substituted thienyl(amino)sulphonylureas |
| 06/09/2005 | US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions |
| 06/09/2005 | DE10353094A1 Verfahren zur Herstellung linearer organischer Thiophen-Phenylen-Oligomere A process for preparing linear organic thiophene-phenylene oligomers |
| 06/09/2005 | CA2547472A1 Cyclic amine derivative having heteroaryl ring |
| 06/09/2005 | CA2546709A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
| 06/09/2005 | CA2546264A1 4-phenylpiperidine derivatives as renin inhibitors |
| 06/09/2005 | CA2545823A1 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof |
| 06/09/2005 | CA2545262A1 Quinazoline derivatives |
| 06/09/2005 | CA2544519A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 06/08/2005 | EP1537087A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
| 06/08/2005 | EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 06/08/2005 | EP1537080A1 Substituted spirocyclic ketoenols |
| 06/08/2005 | EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough |
| 06/08/2005 | EP1536784A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 06/08/2005 | EP1465854A4 Chalcone derivatives and their use to treat diseases |
| 06/08/2005 | EP1268306A4 Inverted aerosol dispenser |
| 06/08/2005 | EP1089735B1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 06/08/2005 | EP1042305B1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
| 06/08/2005 | EP1019045B1 Antithrombotic agents |
| 06/08/2005 | EP0922029B1 Ether muscarinic antagonists |
| 06/08/2005 | CN1625554A Amides of aminoalkyl substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/08/2005 | CN1625410A 2, 4, 6-triamino-1, 3, 5-triazine derivative |
| 06/08/2005 | CN1625401A Non-sedating barbituric acid derivatives |
| 06/08/2005 | CN1625400A 2, 4-pyrimidinediamine compounds and their uses |
| 06/08/2005 | CN1625399A Pharmaceutical composition for regeneration of cirrhotic liver |
| 06/08/2005 | CN1623991A Substituded acza nember 5/nember 6 ring compound and its preparation process |
| 06/08/2005 | CN1623984A Fused-ring compounds and use thereof as drugs |
| 06/08/2005 | CN1623537A Biaryl sulfonamides and its using method |
| 06/08/2005 | CN1205206C Asymmetric diaryl ethylene photochromic compound, and its preparing method and use |
| 06/08/2005 | CN1205198C Cyclic ketone derivative and pharmaceutical use thereof |
| 06/08/2005 | CN1205188C 4,5-dihydro-1h-pyrazole derivatives having CB1-antagonistic activity |
| 06/08/2005 | CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 06/08/2005 | CN1205184C Beta-lactan |
| 06/07/2005 | US6903217 Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them |
| 06/07/2005 | US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 06/07/2005 | US6903121 Treatment of tumors with acetylenes disubstituted with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumor agents |
| 06/07/2005 | US6903115 Bipiperidine compounds |
| 06/07/2005 | US6903112 Nitrogen compounds such as 1-benzenesulfonyl-3-piperidin-3-yl -1H-indole, used as serotonin receptor antagonists, for prophylaxis of nervous system disorders |
| 06/07/2005 | US6903109 Arylindenopyridines and related therapeutic and prophylactic methods |
| 06/07/2005 | US6903104 Antitumor agents, anticarcinogenic agents, a 3-oxoacetamideindolyl compounds, for treating cancer, cytotoxic, and angiogensis inhibitors |
| 06/07/2005 | US6903102 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 06/07/2005 | US6903095 Phthalimido derivatives and a process for their preparation |
| 06/07/2005 | US6903094 As analgesic |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/07/2005 | US6903086 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists |
| 06/07/2005 | US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 06/07/2005 | CA2299036C 4-phenyl-4-heteroarylpiperidine derivatives |
| 06/07/2005 | CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders |
| 06/02/2005 | WO2005049604A2 Antithrombotic aromatic ethers |
| 06/02/2005 | WO2005049594A1 N-acylsulfonamide apoptosis promoters |
| 06/02/2005 | WO2005049593A2 N-acylsulfonamide apoptosis promoters |
| 06/02/2005 | WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases |
| 06/02/2005 | WO2005049578A1 Substituted pyrazoles as ppar agonists |
| 06/02/2005 | WO2005049033A1 Pyrazole derivatives as inhibitors of receptor tyrosyne kinases |
| 06/02/2005 | WO2005048922A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 06/02/2005 | WO2005027823A3 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3) |
| 06/02/2005 | WO2005023794A3 Compound libraries of 4-carboxamidopiperidine derivatives |
| 06/02/2005 | US20050119493 Process for the preparation of amorphous atorvastin calcium salt (2:1) |
| 06/02/2005 | US20050119332 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) |
| 06/02/2005 | US20050119329 Tetronic and tetramic acids |
| 06/02/2005 | US20050119327 1-benzyl-5-[(3-methylphenyl)amino]-3-phenyl-1H-indole-2-carboxylic acid; plasminogen activator inhibitor (PAI-1) inhibitor; fibrinolytic system disorder; atrial fibrillation, pulmonary and renal fibrosis, Alzheimer's disease; anticarcinogenic, antiischemic, anticoagulant, antidiabetic |
| 06/02/2005 | US20050119271 Pyrimidine A2B selective antagonist compounds, their synthesis and use |
| 06/02/2005 | US20050119260 5-(7-Chloro-1-methyl-1H-indol-3-ylmethyl)-3-methyl-imidazolidine-2,4-dione; neurodegenerative and necrotic cell disease; non-apoptotic/caspase-independent cell death mechanisms; ischemia, stroke, cardiac infarction, infection and sepsis |
| 06/02/2005 | US20050119257 Cyclic sulfone containing retroviral protease inhibitors |
| 06/02/2005 | US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2005 | US20050119225 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 06/02/2005 | US20050119182 Bioassay; detect compound as antigonist; antiserotonine agents |
| 06/02/2005 | US20050119168 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease |
| 06/02/2005 | US20050119130 Pyrrolcarboxamides and pyrrolcarbothioamides and their agrochemical uses |
| 06/02/2005 | DE10335545A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis |
| 06/01/2005 | EP1535915A1 Furan or thiophene derivative and medicinal use thereof |
| 06/01/2005 | EP1535909A2 Cyclic amine derivatives and their use as drugs |
| 06/01/2005 | EP1534703A2 Antagonists of melanin concentrating hormone receptor |
| 06/01/2005 | EP1534701A1 Substituted heterocyclylpyrimidines |
| 06/01/2005 | EP1534700A1 Novel thiophene derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 06/01/2005 | EP1534695A2 Tyrosine kinase inhibitors |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534685A1 1h-indazole-3-carboxamide compounds as cyclin dependent kinases (cdk) inhibitors |
| 06/01/2005 | EP1534680A1 Prenylation inhibitors and methods of their synthesis and use |